Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Joske Millecam"'
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
The juvenile conventional pig has been suggested as a preclinical animal model to evaluate pharmacokinetic (PK), pharmacodynamic (PD), and safety parameters in children. However, a lot of developmental changes in pig physiology still need to be unrav
Externí odkaz:
https://doaj.org/article/0c88ffc67e2b472194fa2d70fbfee258
Autor:
Joske Millecam, Thomas van Bergen, Stijn Schauvliege, Gunther Antonissen, Ann Martens, Koen Chiers, Ronette Gehring, Elke Gasthuys, Johan Vande Walle, Siska Croubels, Mathias Devreese
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
Pediatric drug development, especially in disease areas that only affect children, can be stimulated by using juvenile animal models not only for general safety studies, but also to gain knowledge on the pharmacokinetic and pharmacodynamic properties
Externí odkaz:
https://doaj.org/article/c4d4dbb3402e49b4866454f1a3f8afa8
Autor:
Lenka Stroobant, Siska Croubels, Laura Dhondt, Joske Millecam, Siegrid De De Baere, Elke Gasthuys, Joachim Morrens, Gunther Antonissen
Publikováno v:
Animals, Vol 10, Iss 6, p 1027 (2020)
The aim of the current study was to investigate the simultaneous measurement of plasma p-aminohippuric acid (PAH) clearance as a potential marker to assess effective renal plasma flow (eRPF) and tubular secretion (TS), and the plasma clearance of ioh
Externí odkaz:
https://doaj.org/article/8a3398aa54794871bea98b665acbdc8b
Autor:
Joske Millecam, Laura De Clerck, Elisabeth Govaert, Mathias Devreese, Elke Gasthuys, Wim Schelstraete, Dieter Deforce, Lies De Bock, Jan Van Bocxlaer, Stanislas Sys, Siska Croubels
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2018)
Since the implementation of several legislations to improve pediatric drug research, more pediatric clinical trials are being performed. In order to optimize these pediatric trials, adequate preclinical data are necessary, which are usually obtained
Externí odkaz:
https://doaj.org/article/9ad973f3364c4711a25bdbb084907d9a
Autor:
Elke Gasthuys, An Vermeulen, Siska Croubels, Joske Millecam, Stijn Schauvliege, Thomas van Bergen, Pauline De Bruyne, Johan Vande Walle, Mathias Devreese
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2018)
Desmopressin is used to treat primary nocturnal enuresis in children. Over the years, various formulations of desmopressin were commercialized of which the sublingual melt tablet is preferred in the pediatric population, despite the lack of full PK s
Externí odkaz:
https://doaj.org/article/34ab4241331d4b2aa8648090edc7bd4f
Autor:
Elke Gasthuys, Mathias Devreese, Joske Millecam, Stanislas Sys, Katrien Vanderperren, Joris Delanghe, Johan Vande Walle, Marjolein Heyndrickx, Siska Croubels
Publikováno v:
Frontiers in Pharmacology, Vol 8 (2017)
Adequate animal models are required to study the preclinical pharmacokinetics (PK), pharmacodynamics (PD) and safety of drugs in the pediatric subpopulation. Over the years, pigs were presented as a potential animal model, since they display a high d
Externí odkaz:
https://doaj.org/article/c9f0d0f78d1e4c34b101b1ff8a3b41fb
Autor:
Joske Millecam, Ferenc Kelemen, Anto Vrdoljak, Leonida Kutle, Gert Jan Boelm, Lana Ljuma Skupnjak, Davor Janković, Olga Zorman Rojs
Publikováno v:
Viral Immunology. 33:555-564
Infectious bronchitis (IB) is a highly contagious viral disease of chickens, known to cause severe economic losses. Vaccination against IB virus (IBV) is an important control measure against the disease. The objective of the present study was to test
Autor:
Thomas van Bergen, Stijn Schauvliege, Koen Chiers, Joske Millecam, Siska Croubels, Mathias Devreese, Ann Martens, Gunther Antonissen
Publikováno v:
Laboratory Animals. 54:261-271
The use of juvenile conventional pigs as a preclinical animal model to perform pharmacokinetic (PK), pharmacodynamic (PD) and safety studies for the paediatric population is increasing. Repetitive oral administration of drugs to juvenile pigs is howe
Publikováno v:
Animal - science proceedings. 13:168
Autor:
Johan C. A. de Klerk, Pieter L.J. Degraeuwe, Siska Croubels, Sinno H.P. Simons, Karel Allegaert, Swantje Völler, Kian D. Liem, Joske Millecam, Peter Andriessen, Aline G.J. Engbers, Catherijne A. J. Knibbe, Irwin K M Reiss, Robert B. Flint
Publikováno v:
British Journal of Clinical Pharmacology, 86, 10, pp. 2028-2039
British Journal of Clinical Pharmacology, 86(10), 2028-2039. Wiley-Blackwell Publishing Ltd
British Journal of Clinical Pharmacology
British Journal of Clinical Pharmacology, 86, 2028-2039
British Journal of Clinical Pharmacology, 86(10), 2028-2039. Wiley
British Journal of Clinical Pharmacology, 86(10), 2028-2039. Wiley-Blackwell
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
British Journal of Clinical Pharmacology, 86(10), 2028-2039. Wiley-Blackwell Publishing Ltd
British Journal of Clinical Pharmacology
British Journal of Clinical Pharmacology, 86, 2028-2039
British Journal of Clinical Pharmacology, 86(10), 2028-2039. Wiley
British Journal of Clinical Pharmacology, 86(10), 2028-2039. Wiley-Blackwell
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
AIMS: Racemic ibuprofen is widely used for the treatment of preterm neonates with patent ductus arteriosus. Currently used bodyweight-based dosing guidelines are based on total ibuprofen, while only the S-enantiomer of ibuprofen is pharmacologically
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::743f1d8b1372607ba66011e4dea8034b
https://hdl.handle.net/2066/229867
https://hdl.handle.net/2066/229867